184 related articles for article (PubMed ID: 15124069)
1. [Liposomes as ocular drug delivery systems].
Carvalho EL; De la Fuente M; Seijo Rey B
Arch Soc Esp Oftalmol; 2004 Apr; 79(4):151-2. PubMed ID: 15124069
[No Abstract] [Full Text] [Related]
2. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
[TBL] [Abstract][Full Text] [Related]
3. Eyes on new product development: ophthalmic drug delivery.
Novack GD
J Ocul Pharmacol Ther; 2013 Mar; 29(2):90-1. PubMed ID: 23485090
[No Abstract] [Full Text] [Related]
4. Ocular Therapeutics: Drug Delivery and Pharmacology.
Dickmann L
Mol Pharm; 2016 Sep; 13(9):2875-6. PubMed ID: 27596048
[No Abstract] [Full Text] [Related]
5. Ocular drug delivery.
Goepferich A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):157. PubMed ID: 26004820
[No Abstract] [Full Text] [Related]
6. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
7. A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.
Rivers HM; Ray Chaudhuri S; Shah JC; Mittal S
Pharm Res; 2015 Sep; 32(9):2814-23. PubMed ID: 26055402
[No Abstract] [Full Text] [Related]
8. Drug delivery systems for vitreoretinal diseases.
Yasukawa T; Ogura Y; Tabata Y; Kimura H; Wiedemann P; Honda Y
Prog Retin Eye Res; 2004 May; 23(3):253-81. PubMed ID: 15177203
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
10. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
[TBL] [Abstract][Full Text] [Related]
11. Transporters and receptors in ocular drug delivery: opportunities and challenges.
Dey S; Mitra AK
Expert Opin Drug Deliv; 2005 Mar; 2(2):201-4. PubMed ID: 16296747
[TBL] [Abstract][Full Text] [Related]
12. Liposome-mediated drug targeting in topical and regional therapies.
Margalit R
Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):233-61. PubMed ID: 9501970
[TBL] [Abstract][Full Text] [Related]
13. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
[TBL] [Abstract][Full Text] [Related]
14. [Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
Filho PA; Maia M; Rodrigues EB; Farah ME
Arq Bras Oftalmol; 2010; 73(3):294-9. PubMed ID: 20730292
[TBL] [Abstract][Full Text] [Related]
15. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017; 33(1):1-2. PubMed ID: 28080222
[No Abstract] [Full Text] [Related]
16. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
17. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
18. Are contact lenses the solution for effective ophthalmic drug delivery?
Bengani L; Chauhan A
Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101
[No Abstract] [Full Text] [Related]
19. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Apr; 33(3):129-131. PubMed ID: 28384030
[No Abstract] [Full Text] [Related]
20. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
